Evidence map›Paper›PMID 26762116›Full record

ArticleJournal of medical virology2016

Broncholaveolar lavage to detect cytomegalovirus infection, latency, and reactivation in immune competent hosts.

Sara Mansfield, Varun Dwivedi, Sara Byrd, Joanne Trgovcich, Marion Griessl, Michael Gutknecht, Charles H Cook

Open access · greenAbstract read
In one paragraph

Article in Journal of medical virology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Sara MansfieldDivision of Trauma, Critical Care, and Burn, Department of Surgery, Ohio State University College of Medicine, Columbus, Ohio.
Varun DwivediDivision of Trauma, Critical Care, and Burn, Department of Surgery, Ohio State University College of Medicine, Columbus, Ohio.
Sara ByrdDivision of Trauma, Critical Care, and Burn, Department of Surgery, Ohio State University College of Medicine, Columbus, Ohio.
Joanne TrgovcichDivision of Trauma, Critical Care, and Burn, Department of Surgery, Ohio State University College of Medicine, Columbus, Ohio.
Marion GriesslDivision of Acute Care Surgery, Trauma and Surgical Critical Care, Department of Surgery, Beth Israel Deaconess Medical Center-Harvard Medical School, Boston, Massachusetts.
Michael GutknechtDivision of Acute Care Surgery, Trauma and Surgical Critical Care, Department of Surgery, Beth Israel Deaconess Medical Center-Harvard Medical School, Boston, Massachusetts.
Charles H CookDivision of Acute Care Surgery, Trauma and Surgical Critical Care, Department of Surgery, Beth Israel Deaconess Medical Center-Harvard Medical School, Boston, Massachusetts.
The Ohio State University · USHarvard University · US

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Tasleem J Padamsee · 1985 to 2026
$132.3M
Tumor ImmunologyT32CA090223 · NCI · OHIO STATE UNIVERSITY · PI CARSON, WILLIAM E. · 2002 to 2023
$4.1M
Bacterial Sepsis & Reactivation of Latent CytomegalovirusR01GM066115 · NIGMS · OHIO STATE UNIVERSITY · PI COOK, CHARLES H · 2003 to 2014
$2.6M
NCI NIH HHS P30 CA016058NCI NIH HHS T32 CA090223NIAID NIH HHS HHSN272201300006CNIGMS NIH HHS R01 GM066115
6 · The paper itself

Abstract

Roughly 1/3rd of immune competent patients will reactivate latent cytomegalovirus (CMV) during critical illness. There are no standard methods to detect reactivation, and some investigators have postulated that presence of DNA in BAL fluid is indicative of viral replication. To test this hypothesis, we used a murine model that allows inclusion of matched healthy controls which is not possible in human studies. BALB/c mice infected with Smith-murine CMV or PBS (mock) had BAL evaluated 7, 14, or 21 days after acute infections, during latency, or during bacterial sepsis. Plaque assay, PCR, and rtPCR were performed on BALs and concomitantly obtained lung tissue. BAL cellular compositions, including tetramer evaluation of CMV-specific T cells were evaluated by flow cytometry. CMV DNA were detected in BAL at all time-points during acute infection, becoming undetectable in all mice during latency, then were detected again during bacterial sepsis, peaking 3 weeks after onset. mCMV specific T-cells were most numerous in BAL after acute viral infections, decreasing to low levels during latency, then fluctuating during bacterial sepsis. Specifically, mCMV-specific T-cells contracted at sepsis onset, expanding 2-4 weeks post-sepsis, presumably in response to increased viral loads at that time point. Altogether, our results support the use of BAL PCR for the diagnosis of CMV replication in immune competent hosts. Additionally, we demonstrate dynamic changes in CMV-specific T cells that occur in BAL during CMV infection and during sepsis induced viral reactivation. J. Med. Virol. 88:1408-1416, 2016. © 2016 Wiley Periodicals, Inc.

Indexed as

ImmunocompetenceVirus ActivationVirus LatencyAnimalsBronchoalveolar LavageBronchoalveolar Lavage FluidCytomegalovirus InfectionsHumansLungMiceMice, Inbred BALB CMuromegalovirusSepsisT-LymphocytesViral LoadVirus Replicationcytomegalovirusimmune responses, reactivationinfectioninfection, latent infectionvirus classification, T cell

Identifiers

PMID26762116
PMCPMC4915565
OpenAlexW2235950412

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.